Calamos Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $47.4M | Hold |
|
|||||
|
2025
Q2 | $45.1M | Buy |
|
|||||
|
2025
Q1 | $45M | Buy |
|
|||||
|
2024
Q4 | $43.6M | Buy |
|
|||||
|
2024
Q3 | $27.9M | Sell |
|
|||||
|
2024
Q2 | $27.7M | Sell |
|
|||||
|
2024
Q1 | $37.4M | Sell |
|
|||||
|
2023
Q4 | $39.5M | Sell |
|
|||||
|
2023
Q3 | $45.9M | Buy |
|
|||||
|
2023
Q2 | $50.7M | Buy |
|
|||||
|
2023
Q1 | $56.4M | Sell |
|
|||||
|
2022
Q4 | $77.6M | Sell |
|
|||||
|
2022
Q3 | $75.5M | Sell |
|
|||||
|
2022
Q2 | $97.7M | Buy |
|
|||||
|
2022
Q1 | $89.7M | Buy |
|
|||||
|
2021
Q4 | $91.5M | Sell |
|
|||||
|
2021
Q3 | $67.4M | Buy |
|
|||||
|
2021
Q2 | $54.4M | Buy |
|
|||||
|
2021
Q1 | $41.3M | Buy |
|
|||||
|
2020
Q4 | $41M | Sell |
|
|||||
|
2020
Q3 | $42.2M | Sell |
|
|||||
|
2020
Q2 | $46M | Sell |
|
|||||
|
2020
Q1 | $47.9M | Sell |
|
|||||
|
2019
Q4 | $133M | Buy |
|
|||||
|
2019
Q3 | $117M | Sell |
|
|||||
|
2019
Q2 | $146M | Buy |
|
|||||
|
2019
Q1 | $123M | Buy |
|
|||||
|
2018
Q4 | $96.1M | Buy |
|
|||||
|
2018
Q3 | $91M | Sell |
|
|||||
|
2018
Q2 | $76.8M | Buy |
|
|||||
|
2018
Q1 | $71.5M | Buy |
|
|||||
|
2017
Q4 | $71.9M | Sell |
|
|||||
|
2017
Q3 | $72.5M | Buy |
|
|||||
|
2017
Q2 | $67.2M | Sell |
|
|||||
|
2017
Q1 | $73.5M | Sell |
|
|||||
|
2016
Q4 | $92.1M | Sell |
|
|||||
|
2016
Q3 | $96.3M | Sell |
|
|||||
|
2016
Q2 | $100M | Sell |
|
|||||
|
2016
Q1 | $84.6M | Buy |
|
|||||
|
2015
Q4 | $90.8M | Buy |
|
|||||
|
2015
Q3 | $88M | Sell |
|
|||||
|
2015
Q2 | $94.3M | Sell |
|
|||||
|
2015
Q1 | $99.6M | Buy |
|
|||||
|
2014
Q4 | $80.5M | Buy |
|
|||||
|
2014
Q3 | $58.4M | Sell |
|
|||||
|
2014
Q2 | $58.6M | Buy |
|
|||||
|
2014
Q1 | $61.9M | Hold |
|
|||||
|
2013
Q4 | $59M | Sell |
|
|||||
|
2013
Q3 | $61.1M | Sell |
|
|||||
|
2013
Q2 | $107M | Buy |
|